In this study, we have mapped and characterized a
B cell epitope of sulfated
glycoprotein ZP2 (ZP2) as a step toward the development of a multi-
epitope zona pellucida (ZP)
vaccine. Recombinant
polypeptides expressed by random
deoxyribonuclease-digested fragments of ZP2
cDNA were screened for binding to IE-3, a
monoclonal antibody to murine ZP2. Positive clones contained
cDNA inserts encoding
polypeptide corresponding to ZP2(103-134). When normal or ovariectomized female mice were immunized with three overlapping
peptides that span this region of ZP2 (101-120, 111-130, 121-140), only ZP2(121-140) elicited
IgG antibodies that reacted with mouse ovarian ZP, indicative of the presence of native B
epitope and helper T cell
epitope in ZP2(121-140). To more finely map the ZP2
B cell epitope, a random
peptide display library was screened with the IE-3 antibody, and a consensus tetramer sequence VxYK that matched the ZP2(123-126) sequence VRYK was located. Competitive immunofluorescence analysis with single
alanine-substituted VxYK
peptides ranked the relative contribution of the three critical
B cell epitope residues as Y > V > K. A chimeric
peptide was constructed that contained the YRYK motif of ZP2 and a bovine
RNase T cell
epitope. Although (C57BL/6xA/J) F1 (B6AF1) female mice immunized with the chimeric
peptide developed ZP antibody response, this
peptide elicited antibody only in mice of the histocompatibility complex (MHC) H-2(k or b) haplotype. In contrast, ZP2(121-140)
peptide elicited antibody in inbred mice with three additional mouse MHC haplotypes. Moreover, although ZP2(121-140) contained a
T cell epitope, no
oophoritis was observed after immunization of B6AF1 mice with ZP2(121-140) in complete
Freund's adjuvant (CFA). In a preliminary trial, female B6AF1 mice immunized with ZP2(121-140) in CFA had reduced litter sizes as compared with mice injected with CFA alone.